PRO ISRAEL

Can-Fite BioPharma Ltd.

NYSE: CANF

The chart fills in as daily closes arrive.

52-week range

End-of-day prices. Not live quotes, and not investment advice.

Funding and exits

No funding round or acquisition of Can-Fite BioPharma Ltd. has been reported on this site yet.

Can-Fite BioPharma Ltd. in the news

No business news about Can-Fite BioPharma Ltd. yet.

More in Pharma & biotech

The whole industry
Other companies in Pharma & biotech
CompanyIndustryListedCloseDayMarket value
BioLineRx Ltd.Pharma & biotechNasdaq: BLRX
Chemomab Therapeutics Ltd.Pharma & biotechNasdaq: CMMB
Compugen Ltd.Pharma & biotechNasdaq: CGEN
Enlivex Ltd.Pharma & biotechNasdaq: ENLV
Entera Bio Ltd.Pharma & biotechNasdaq: ENTX
Galmed Pharmaceuticals Ltd.Pharma & biotechNasdaq: EOCN